Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Octaura Secures $46.5 Million to Accelerate Growth in The Evolving CLO and Leveraged Loan Markets
-
Newton Golf CEO Greg Campbell to Headline IBN’s TableTalk Series Following Record Revenue Growth
-
Dispel Announces Industry's First Tiered Connection Suite for OT Secure Remote Access at the Gartner(R) Security & Risk Management Summit 2025
-
Pactum Secures $54 Million in Series C Funding to Scale Agentic AI in Procurement
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
meshIQ Enhances Apache ActiveMQ(R) Offerings and Welcomes Apache Software Foundation Member JB Onofre
-
BitMEX Launches June Jumpstart Trading Competition: Win from a 3 BTC Prize Pool
-
NV5 Awarded $5 Million in High-Voltage Data Center Substation Design Services
-
Newlyweds Say 'I Do' to Love, But 'I Don't' to Estate Planning: 42% of Couples Haven't Created One
-
Alternative Investments Aren’t for Everyone
-
ELV INVESTOR REMINDER: BFA Law Reminds Elevance Health, Inc. Investors to Contact the Firm by the July 11 Class Action Deadline
-
Bitcoin Solaris Presale Heats Up in Phase 7 as Token Launch Nears with 233% ROI Forecast
-
XRP News: Nimanode Presale Explodes Past 11% of Softcap as Major Whale’s move in to Buy NMA
-
RDDT INVESTOR REMINDER: BFA Law Reminds Reddit, Inc. Investors to Contact the Firm about its Pending Securities Investigation
-
OGN INVESTOR REMINDER: BFA Law Reminds Organon & Co. Investors to Contact the Firm by the July 22 Class Action Deadline
-
EDM Announces New US$58 Million Gypsum Offtake Agreement
-
eDesign Interactive Launches New Website for Yen Press to Streamline Publishing and Deliver an Immersive Reader Experience
-
URGN INVESTOR REMINDER: BFA Law Reminds UroGen Pharma Ltd. Investors to Contact the Firm by the July 28 Class Action Deadline
-
IOVA INVESTOR REMINDER: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors to Contact the Firm by the July 14 Class Action Deadline
-
FTRE INVESTOR NOTICE: BFA Law Reminds Fortrea Holdings Inc. Investors to Contact the Firm by the August 1 Class Action Deadline
-
CODI INVESTOR REMINDER: BFA Law Reminds Compass Diversified Holdings Investors to Contact the Firm by the July 8 Class Action Deadline
-
XCF Global Begins Trading on Nasdaq Under Ticker Symbol "SAFX"
-
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
-
HLRBO Debuts Mobile App to Give Hunters Nationwide Access to Hunting Land at Their Fingertips
-
CIVI INVESTOR REMINDER: BFA Law Reminds Civitas Resources, Inc. Investors to Contact the Firm by the July 1 Class Action Deadline
-
Books.by Launches Self-Publishing Platform Offering Authors 100% Royalties and Complete Sales Transparency
-
Carrier Unveils Bold New Brand Identity, Purpose and Tagline, Marking a New Era of Global Leadership
-
First Andes Silver Mobilizes Rig for Second Drill Program at Santas Gloria Project, Targeting Extension of High-Grade Silver Discovery at Depth
-
Seabridge Gold Reports Achievements in Safety, Diversity, and Environmental Stewardship
-
Dexterra Group Announces Expansion and Extension of Credit Facility
-
Standard Uranium Announces Exploration Plans at the Corvo Project with Option Partner Aventis Energy Inc.
-
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
-
CSW Industrials Announces the Commencement of Trading on the New York Stock Exchange and Ticker Symbol Change
-
Canaan Inc. Announces Share Purchases by Chief Executive Officer and Chief Financial Officer
-
SBS ANNOUNCES GROUNDBREAKING PARTNERSHIP WITH THE ROKU CHANNEL FOR LIVESTREAMING THE NEW LAMUSICA TV
-
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
-
Okomera Opens Pre-orders for Ocentra, the Central Engine for Automated Organoid Screening
-
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Exp
-
Matador Technologies Announces Strategic Advisory Board Featuring Leaders from Bitcoin and Gold
-
Exro Technologies Provides Corporate Update
-
DiPilla Dentistry Debuts New, Larger Birmingham Office
-
SUNSTONE HOTEL INVESTORS ANNOUNCES THE DISPOSITION OF HILTON NEW ORLEANS ST. CHARLES
-
Palvella Therapeutics Receives Initial Proceeds from FDA Orphan Products Grant to Support Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
-
Birks Group Provides a Corporate Update
-
Almonty Receives U.S. Congressional Recognition for Strategic Role in U.S. Critical Minerals Supply Chain
-
Plug Power and Allied Green Expand Strategic Collaboration with New 2 GW Electrolyzer Deal in Uzbekistan
-
Alarum Technologies Updates Second Quarter 2025 Revenue and Adjusted EBITDA Outlook
-
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Seconda
-
LeddarTech Enters into Further Amendments to Credit Facility and Bridge Financing Offer and Announces the Return to Work of Certain Employees Following Furlough
-
Ranchero Gold Announces Director Appointment
